Results 141 to 150 of about 43,736 (227)

NOTCH2NLC Repeat Expansions in Parkinsonian Disorders: Clinical and Neuroimaging Characteristics. [PDF]

open access: yesAnn Clin Transl Neurol
Chiang HL   +7 more
europepmc   +1 more source

Moving beyond the hospital: in-depth characterization of daily-life mobility in patients with atypical Parkinsonian disorders. [PDF]

open access: yesNPJ Parkinsons Dis
Sidoroff V   +23 more
europepmc   +1 more source

Serious Illness Conversation in the Care of Atypical Parkinsonian Disorders: A Practical Guide for Neurology Clinicians. [PDF]

open access: yesMov Disord Clin Pract
Bruno MK   +7 more
europepmc   +1 more source

Cell Death in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets

open access: yesMedComm, Volume 7, Issue 9, September 2026.
Regulated cell death pathways, including apoptosis, necroptosis, pyroptosis, ferroptosis, and autophagy‐dependent cell death, interact with mitochondrial dysfunction, proteostasis failure, lysosomal stress, glial remodeling, and neuroinflammation across major neurodegenerative diseases.
Tianjiao Li   +3 more
wiley   +1 more source

Corticotropin-releasing hormone as a candidate biomarker for parkinsonian disorders. [PDF]

open access: yesBrain Commun
Fernandes Gomes B   +9 more
europepmc   +1 more source

Clinical characteristics and risk factors associated with consultation‐confirmed delirium in hospitalized patients

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.
Abstract Aim Delirium, a serious neuropsychiatric hospitalization complication, is a manifestation of underlying neurocognitive vulnerability rather than an acute event. In Japan, a nationwide medical policy mandates early hospital‐wide delirium risk screening to evaluate predefined risk factors in inpatient populations.
Megumi Matsuda   +12 more
wiley   +1 more source

Integrating tele-palliative care for atypical Parkinsonian disorders: Lessons learned from a pilot program. [PDF]

open access: yesClin Park Relat Disord
Afshari M   +7 more
europepmc   +1 more source

Peripheral κ opioid receptor in pain and inflammation: From molecular signalling and gene expression to drug discovery

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 17, Page 5157-5189, September 2026.
The κ opioid receptor (κ receptor, KOR) is a G protein‐coupled receptor with well established roles in analgesia and immune modulation. Although historically studied primarily in the central nervous system (CNS), growing evidence indicates that κ signalling in peripheral tissues plays an important role in regulating pain, inflammation and immune ...
Rumsha Khan   +3 more
wiley   +1 more source

Rational Design of Multifunctional Tacrine Derivatives as Candidates for the Treatment of Alzheimer and Parkinson Diseases

open access: yesChemMedChem, Volume 21, Issue 15, 14 August 2026.
We present a set of multifunctional tacrine derivatives, designed with the CADMA‐Chem protocol, aimed for Alzheimer and Parkinson diseases. Of the tacrines designed, TAC‐674 and TAC‐678 are the best candidates to act as multifunctional antioxidants and neuroprotectors for Alzheimer and Parkinson diseases, respectively.
Eugenia Dzib   +3 more
wiley   +1 more source

A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders: A Consensus Statement. [PDF]

open access: yesNeurol Clin Pract
Bruno MK   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy